Tesamorelin / Ipamorelin Blend – 10mg/3mg

This research-only formulation combines Tesamorelin, a synthetic growth hormone-releasing factor (GRF) analog, with Ipamorelin, a selective ghrelin receptor agonist. Tesamorelin is studied for its ability to stimulate endogenous growth hormone release and modulate IGF-1 levels, while Ipamorelin supports targeted GH secretion without affecting cortisol or prolactin. Together, this blend is investigated for its potential roles in body composition, metabolic regulation, and recovery support.